Analyze Diet

Selected microRNAs as biomarkers in sarcoid-affected horses under immunotherapy with a mistletoe extract.

Abstract: We investigated microRNAs (miRNAs) as potential prognostic biomarkers for equine sarcoid (ES) disease. In a breed-, age-, and sex-matched case-controlled study involving 45 ES-affected and 15 control horses, we assessed the diagnostic, prognostic, and theragnostic value of 3 miRNAs (eca-miR-127, eca-miR-379, eca-miR-432) in horses treated with European mistletoe () extract versus placebo. Whole-blood miRNA concentrations were measured using reverse-transcription quantitative real-time PCR (RT-qPCR) at 3 different times. We found that eca-miR-432 expression was lower in ES-affected (median = -1.93; 95% CI: -2.03 to -.86) compared to control (median = -1.71; 95% CI: -1.92 to -1.6) horses ( = 0.03,  = 0.3; 95% CI: 0.024-0.57) with a median difference of -1.93 versus -1.71, respectively. The ROC curve analysis indicated an area under the curve of 0.71 (95% CI: 0.51-0.84;  = 0.005) with a sensitivity of 74% (95% CI: 61-88%) and a specificity of 73% (95% CI: 39-94%) to diagnose ES. However, none of the miRNAs evaluated had prognostic potential or significant changes in expression following treatment. Additionally, miRNA expression was not influenced by breed, sex, or season. Although whole-blood eca-miR-432 had moderate diagnostic potential for ES, identifying prognostic miRNA biomarkers for ES remains a challenge.
Publication Date: 2025-10-03 PubMed ID: 41039872PubMed Central: PMC12494582DOI: 10.1177/10406387251362820Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Cite This Article

APA
Beermann A, Hamza E, Reinhard S, Koch C, Oberhänsli T, Unger L. (2025). Selected microRNAs as biomarkers in sarcoid-affected horses under immunotherapy with a mistletoe extract. J Vet Diagn Invest, 38(1), 33-40. https://doi.org/10.1177/10406387251362820

Publication

ISSN: 1943-4936
NlmUniqueID: 9011490
Country: United States
Language: English
Volume: 38
Issue: 1
Pages: 33-40
PII: 10406387251362820

Researcher Affiliations

Beermann, Anke
  • Departments of Livestock Sciences, Soil Sciences and Crop Sciences (FiBL), Research Institute of Organic Agriculture, Frick, Switzerland.
Hamza, Eman
  • Department of Zoonoses, Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt.
Reinhard, Sonja
  • Departments of Livestock Sciences, Soil Sciences and Crop Sciences (FiBL), Research Institute of Organic Agriculture, Frick, Switzerland.
Koch, Christoph
  • Department of Clinical Veterinary Medicine, Swiss Institute of Equine Medicine (ISME), Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Oberhänsli, Thomas
  • Departments of Livestock Sciences, Soil Sciences and Crop Sciences (FiBL), Research Institute of Organic Agriculture, Frick, Switzerland.
Unger, Lucia
  • Department of Clinical Veterinary Medicine, Swiss Institute of Equine Medicine (ISME), Vetsuisse Faculty, University of Bern, Bern, Switzerland.

MeSH Terms

  • Animals
  • Horses
  • Horse Diseases / diagnosis
  • Horse Diseases / blood
  • Horse Diseases / therapy
  • Horse Diseases / drug therapy
  • MicroRNAs / blood
  • MicroRNAs / genetics
  • MicroRNAs / metabolism
  • Male
  • Female
  • Biomarkers / blood
  • Plant Extracts / therapeutic use
  • Sarcoidosis / veterinary
  • Sarcoidosis / diagnosis
  • Sarcoidosis / drug therapy
  • Sarcoidosis / therapy
  • Sarcoidosis / blood
  • Case-Control Studies
  • Immunotherapy / veterinary
  • Viscum album / chemistry

Conflict of Interest Statement

Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

This article includes 56 references
  1. Barrey E, et al. Muscular microRNA expressions in healthy and myopathic horses suffering from polysaccharide storage myopathy or recurrent exertional rhabdomyolysis. Equine Vet J Suppl 2010;38:303–310.
    pubmed: 21059022
  2. Beermann A, et al. A randomized placebo-controlled double-blinded study comparing oral and subcutaneous administration of mistletoe extract for the treatment of equine sarcoid disease. J Vet Intern Med 2024;38:1815–1824.
    pmc: PMC11099770pubmed: 38529853
  3. Berruex F, et al. Clinical course of sarcoids in 61 Franches-Montagnes horses over a 5–7 year period. Vet Q 2016;36:189–196.
    pubmed: 27327513
  4. Bogedale K, et al. Differentially expressed microRNAs, including a large microRNA cluster on chromosome 24, are associated with equine sarcoid and squamous cell carcinoma. Vet Comp Oncol 2019;17:155–164.
    pubmed: 30684296
  5. Bovell LC, et al. The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer. Clin Cancer Res 2013;19:3955–3965.
    pmc: PMC3746330pubmed: 23719259
  6. Bustin SA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009;55:611–622.
    pubmed: 19246619
  7. Calewaert A, et al. Comparison of serum microRNA in healthy horses and horses with moderate to severe mitral valve regurgitation using a commercially available canine cardiac panel. Equine Vet J 2025;57:1001–1008.
    pubmed: 39567225
  8. Carver C, et al. Effects of corn supplementation on serum and muscle microRNA profiles in horses. Food Sci Nutr 2023;11:2811–2822.
    pmc: PMC10261821pubmed: 37324886
  9. Chambers G, et al. Association of bovine papillomavirus with the equine sarcoid. J Gen Virol 2003;84:1055–1062.
    pubmed: 12692268
  10. Chen S, et al. Identification of prognostic miRNA signature and lymph node metastasis-related key genes in cervical cancer. Front Pharmacol 2020;11:544.
    pmc: PMC7226536pubmed: 32457603
  11. Christen G, et al. Inheritance of equine sarcoid disease in Franches-Montagnes horses. Vet J 2014;199:68–71.
    pubmed: 24152383
  12. nChristen-Clottu O, et al. Treatment of clinically diagnosed equine sarcoid with a mistletoe extract (). J Vet Intern Medn2010;24:1483–1489.n
    pubmed: 21039860
  13. Cosandey J, et al. Diagnostic and prognostic potential of eight whole blood microRNAs for equine sarcoid disease. PLoS One 2021;16:e0261076.
    pmc: PMC8699634pubmed: 34941894
  14. Cui C, et al. Identification and analysis of human sex-biased microRNAs. Genom Proteom Bioinform 2018;16:200–211.
    pmc: PMC6076379pubmed: 30005964
  15. Dini P, et al. Expression profile of the chromosome 14 microRNA cluster (C14MC) ortholog in equine maternal circulation throughout pregnancy and its potential implications. Int J Mol Sci 2019;20:6285.
    pmc: PMC6941126pubmed: 31847075
  16. nEggenschwiler J, et al. Mistletoe lectin is not the only cytotoxic component in fermented preparations of from white fir (). BMC Complement Altern Medn2007;7:14.n
    pmc: PMC1878504pubmed: 17493268
  17. Guo L, et al. MiRNA and mRNA expression analysis reveals potential sex-biased miRNA expression. Sci Rep 2017;7:39812.
    pmc: PMC5206641pubmed: 28045090
  18. Gysens L, et al. Cross-sectional comparison of superficial swab and fine-needle aspiration: improving the diagnostic workup of horses with sarcoids. Vet J 2022;289:105916.
    pubmed: 36272685
  19. Gysens L, et al. Longitudinal pilot study examining the effect of punch biopsy on equine sarcoid growth dynamics. Vet Dermatol 2024;35:148–155.
    pubmed: 38168049
  20. Hamza E, et al. The potential of three whole blood microRNAs to predict outcome and monitor treatment response in sarcoid-bearing equids. Vet Res Commun 2023;47:87–98.
    pmc: PMC9873782pubmed: 35484337
  21. Haspeslagh M, et al. The clinical diagnosis of equine sarcoids—Part 2: assessment of case features typical of equine sarcoids and validation of a diagnostic protocol to guide equine clinicians in the diagnosis of equine sarcoids. Vet J 2018;240:14–18.
    pubmed: 30268326
  22. Huang RS, et al. Population differences in microRNA expression and biological implications. RNA Biol 2011;8:692–701.
    pmc: PMC3225983pubmed: 21691150
  23. Knottenbelt DC. A suggested clinical classification for the equine sarcoid. Clin Tech Equine Pract 2005;4:278–295.
  24. Knottenbelt DC. Pascoe’s principles and practice of equine dermatology. Elsevier Health Sci, 2009.
  25. Koch C, et al. The clinical diagnosis of equine sarcoids. Part 1: assessment of sensitivity and specificity using a multicentre case-based online examination. Vet J 2018;242:77–82.
    pubmed: 30195623
  26. Laurell H, et al. Correction of RT-qPCR data for genomic DNA-derived signals with ValidPrime. Nucleic Acids Res 2012;40:e51.
    pmc: PMC3326333pubmed: 22228834
  27. nLee DK.nAlternatives to value: confidence interval and effect size. Korean J Anesthesioln2016;69:555–562.n
    pmc: PMC5133225pubmed: 27924194
  28. Ludwig N, et al. Spring is in the air: seasonal profiles indicate vernal change of miRNA activity. RNA Biol 2019;16:1034–1043.
    pmc: PMC6602417pubmed: 31035857
  29. Lunardi M, et al. Bovine papillomavirus type 13 DNA in equine sarcoids. J Clin Microbiol 2013;51:2167–2171.
    pmc: PMC3697707pubmed: 23637294
  30. nMangla P.nAnomaly detection: how to find outliers using the Grubbs test. PyImageSearch. 2025 Jan 6. https://pyimagesearch.com/2025/01/06/anomaly-detection-how-to-find-outliers-using-the-grubbs-test/ 2025.
  31. nMarco A.nSex-biased expression of microRNAs in . Open Bioln2014;4:140024.n
    pmc: PMC4043116pubmed: 24694940
  32. Martens A, et al. PCR detection of bovine papilloma virus DNA in superficial swabs and scrapings from equine sarcoids. Vet J 2001;161:280–286.
    pubmed: 11352485
  33. nMukherjee K, et al. Seasonal phenotype-specific expression of microRNAs during metamorphosis in the European map butterfly . Arch Insect Biochem Physioln2020;104:e21657.
    pubmed: 31960991
  34. Nagy Á, et al. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep 2018;8:11515.
    pmc: PMC6060132pubmed: 30046141
  35. O’Brien J, et al. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) 2018;9:402.
    pmc: PMC6085463pubmed: 30123182
  36. Pacholewska A, et al. Novel equine tissue miRNAs and breed-related miRNA expressed in serum. BMC Genomics 2016;17:831.
    pmc: PMC5080802pubmed: 27782799
  37. Pawlina K, et al. Comprehensive characteristics of microRNA expression profile of equine sarcoids. Biochimie 2017;137:20–28.
    pubmed: 28259757
  38. Pollard J, et al. Differential expression of microRNAs in breast cancers from four different ethnicities. Pathobiology 2018;85:220–226.
    pubmed: 29791912
  39. Sanchita, et al. Dietary plant miRNAs as an augmented therapy: cross-kingdom gene regulation. RNA Biol 2018;15:1433–1439.
    pmc: PMC6333437pubmed: 30474479
  40. Schaffer PA, et al. Cutaneous neoplastic lesions of equids in the central United States and Canada: 3,351 biopsy specimens from 3,272 equids (2000–2010). J Am Vet Med Assoc 2013;242:99–104.
    pubmed: 23234288
  41. Staiger EA, et al. Host genetic influence on papillomavirus-induced tumors in the horse. Int J Cancer 2016;139:784–792.
    pubmed: 27037728
  42. Stein EV, et al. Steps to achieve quantitative measurements of microRNA using two step droplet digital PCR. PLoS One 2017;12:e0188085.
    pmc: PMC5690473pubmed: 29145448
  43. Terron-Canedo N, et al. Differential expression of microRNAs in bovine papillomavirus type 1 transformed equine cells. Vet Comp Oncol 2017;15:764–774.
    pubmed: 27039895
  44. Tiwari A, et al. Seasonal variation in miR-328-3p and let-7d-3p are associated with seasonal allergies and asthma symptoms in children. Allergy Asthma Immunol Res 2021;13:576–588.
    pmc: PMC8255344pubmed: 34212545
  45. Unger L, et al. Diagnostic potential of three serum microRNAs as biomarkers for equine sarcoid disease in horses and donkeys. J Vet Intern Med 2021;35:610–619.
    pmc: PMC7848377pubmed: 33415768
  46. Unger L, et al. MicroRNA fingerprints in serum and whole blood of sarcoid-affected horses as potential non-invasive diagnostic biomarkers. Vet Comp Oncol 2019;17:107–117.
    pubmed: 30430738
  47. Unger L, et al. Differences in miRNA differential expression in whole blood between horses with sarcoid regression and progression. J Vet Intern Med 2019;33:241–250.
    pmc: PMC6335546pubmed: 30506726
  48. Valentine BA. Survey of equine cutaneous neoplasia in the Pacific Northwest. J Vet Diagn Invest 2006;18:123–126.
    pubmed: 16566271
  49. Wang C, et al. Droplet digital PCR improves urinary exosomal miRNA detection compared to real-time PCR. Clin Biochem 2019;67:54–59.
    pubmed: 30905583
  50. Warnefors M, et al. Sex-biased microRNA expression in mammals and birds reveals underlying regulatory mechanisms and a role in dosage compensation. Genome Res 2017;27:1961–1973.
    pmc: PMC5741053pubmed: 29079676
  51. Xiang M, et al. U6 is not a suitable endogenous control for the quantification of circulating microRNAs. Biochem Biophys Res Commun 2014;454:210–214.
    pubmed: 25450382
  52. nXie W, et al. Identification of L. MiRNAs and prediction of their medicinal values. PLoS Onen2017;12:e0187776.
    pmc: PMC5675405pubmed: 29112983
  53. Xie W, Melzig MF. The stability of medicinal plant microRNAs in the herb preparation process. Molecules 2018;23:919.
    pmc: PMC6016954pubmed: 29659501
  54. Zehavi L, et al. Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. Mol Cancer 2012;11:44.
    pmc: PMC3444916pubmed: 22747855
  55. Zhong B, et al. Identification and analysis of sex-biased microRNAs in human diseases. Genes (Basel) 2023;14:1688.
    pmc: PMC10531062pubmed: 37761827
  56. Zhong S, et al. MiRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer. Transl Res 2021;230:164–196.
    pubmed: 33253979

Citations

This article has been cited 0 times.